omalizumab
NICE approves Roche’s Gazyvaro and Novartis’ Xolair
March 11, 2015Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab
NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …
NICE wants more Xolair data
November 19, 2014Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab
Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …
Latest content
